Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
about
B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?Efficacy of gene therapy for X-linked severe combined immunodeficiencyLong-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyImproving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a reviewTransplantation immunology: solid organ and bone marrow.Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.Transplantation outcomes for severe combined immunodeficiency, 2000-2009.Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.Hematopoietic cell transplantation for treatment of primary immune deficiencies.Long-lasting production of new T and B cells and T-cell repertoire diversity in patients with primary immunodeficiency who had undergone stem cell transplantation: a single-centre experience.The long and the short of telomeres in bone marrow recipient SCID patients.A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningHigh-throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia.Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.Post-transplantation B cell function in different molecular types of SCIDThe natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis.Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics.Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsoClinical and imaging considerations in primary immunodeficiency disorders: an update.Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumHaematopoietic stem cell transplantation for severe combined immunodeficiency: Long-term health outcomes and patient perspectives.Clonal and constricted T cell repertoire in Common Variable Immune Deficiency.Defective thymic output in WAS patients is associated with abnormal actin organization.Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey.Molecular measurement of T cell receptor excision circles.Long term outcomes of severe combined immunodeficiency: therapy implications.Severe combined immunodeficiencies and related disorders.American Pediatric Society's 2014 John Howland Award acceptance lecture: saving lives through early diagnosis.Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3δ deficiency.
P2860
Q26828763-580CDF77-93CE-4787-B9EF-AE0E97365D2AQ28288838-A8ED2526-5EF3-4633-8974-EE087AE7AF92Q33395718-5686C498-9DF6-4027-A85E-F76FEED27BDFQ33700953-E07781F9-84B4-4C0E-92D1-D42F300D7403Q33803725-72A90EF2-9A5B-4E35-81BD-66AA20F08EB8Q33803804-FDFC5FFB-8BF9-4404-9456-EA1569470B97Q34230150-794E52C6-DBAE-47B5-B4E9-6842A3C310D7Q34279715-3CD9E3A6-7D9F-4480-97E6-B8EF21BE3A53Q34294647-5F0C7249-F2E7-457B-BDF1-9DA8368145D7Q34383907-4E392A20-974A-438C-9B9E-240B4B4900B1Q34729193-67F38DCD-972C-4458-8587-F8FB678608C0Q34796050-88330B45-7124-450A-820D-9FB6B9609387Q35488784-70272A5E-6676-4040-8375-5834B685317DQ35672829-C49A161C-EA12-4F0F-9D40-BD6CE0B27016Q35728637-EEB72C26-10B6-4785-B27C-CA3D15865966Q36315726-C5AEEDEF-CC5F-4AF2-B9A5-28CC3011178EQ36319846-78A4EC39-8595-4A61-8630-EC296A522890Q36546267-BD832D0D-46B7-4D3A-B3CD-CEE2B053E3E5Q37201035-D84BB22B-6D17-4159-B65D-D1874677C01EQ37233057-C01E6A12-A031-4DF6-BFC4-020508250F97Q37442494-F597E0A8-A79B-45A5-9950-970F94C739D3Q38102101-0FAF3704-C839-48E1-B487-400DF15257DFQ38289442-D186EB34-E195-475F-97F2-667A3E42EE8FQ38772827-39948DC2-8A3B-4B92-96DC-1C398D9E563EQ38961320-6043A825-1523-4DCF-8A15-19749C8F7200Q39289010-5257E3C9-BC9A-4273-8408-7FCE83CB7E32Q40209304-A1E70BF8-FB08-4A5F-99B8-84B8147C9EAEQ41538350-6B3F133E-CE75-46C4-87C8-492ED8FC1CBCQ41697178-B4182ACF-47D2-421F-9C5A-8F9664D6C511Q42573665-E356BC65-BEC3-45B3-99A8-C39CF3EB4388Q43082815-94D22327-6224-41F4-AB76-F9951BC6693CQ45872036-063C4E13-7EDC-48C5-9C0F-AFB6069EA8BAQ45886049-B07AAD4E-59B7-4B5D-82F9-B8215AEFAFCAQ48065726-62235258-D4BA-4105-8CC3-264AF03D5B7AQ53141611-D06FA5AA-87B9-4547-805D-1DE1288F3D60
P2860
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@en
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@nl
type
label
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@en
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@nl
prefLabel
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@en
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@nl
P2093
P2860
P1433
P1476
Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.
@en
P2093
Barry K Moser
Chan M Win
Joseph L Roberts
Marcella Sarzotti-Kelsoe
Myriah Cooney
Rebecca H Buckley
Roberta E Parrott
P2860
P304
P356
10.1182/BLOOD-2009-01-199323
P407
P577
2009-05-11T00:00:00Z